News
Important Only
Trump signs order restricting research that enhances pathogens
WASHINGTON, May 5 (Reuters) - U.S. President Donald Trump signed an executive order on Monday that bans federal funding for gain-of-function research that typically enhances pathogens.The order also paused any research using "infectious pathogens and toxins in the United States" that could b...Reuters
Mon, May 5
Bristol Myers to invest $40 billion in the US over 5 years, CEO says
May 5 (Reuters) - Bristol Myers Squibb BMY.N will spend $40 billion in the US over the next five years, CEO Christopher Boerner wrote in an opinion piece published by Stat News on Monday.The money will be spread across research and development, technology and domestic manufacturing, Boerner said.Reuters
Mon, May 5
Xenetic Biosciences Inc expected to post a loss of 72 cents a share - Earnings Preview
Xenetic Biosciences Inc XBIO.OQ XBIO.O is expected to show a rise in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025The Framingham Massachusetts-based company is expected to report a 31.2% increase in revenue to $670 thousand from $510.82 thousand...Reuters
Mon, May 5
Trump to continue Biden's court defense of abortion drug mifepristone
Government lawyers seek dismissal of lawsuitRepublican-led states challenge easier access to abortion drugUS Supreme Court rejected challenge by anti-abortion groupsBy Daniel Wiessner May 5 (Reuters) - President Donald Trump's administration on Monday pushed forward in defending U.S. rules ea...Reuters
Mon, May 5
Smith Micro Software Inc expected to post a loss of 11 cents a share - Earnings Preview
Smith Micro Software Inc SMSI.OQ SMSI.O is expected to show a fall in quarterly revenue when it reports results on May 7 for the period ending March 31 2025The Pittsburgh Pennsylvania-based company is expected to report a 10.2% decrease in revenue to $5.209 million from $5.8 million a year ago, ac...Reuters
Mon, May 5
Excelerate Energy Inc expected to post earnings of 39 cents a share - Earnings Preview
Excelerate Energy Inc EE.N, EE is expected to show a rise in quarterly revenue when it reports results on May 7 for the period ending March 31 2025The The Woodlands Texas-based company is expected to report a 3.9% increase in revenue to $207.868 million from $200.11 million a year ago, according t...Reuters
Mon, May 5
Hudson Pacific Properties Inc expected to post a loss of 41 cents a share - Earnings Preview
Hudson Pacific Properties Inc HPP.N, HPP is expected to show a fall in quarterly revenue when it reports results on May 7 for the period ending March 31 2025The Los Angeles California-based company is expected to report a 5.0% decrease in revenue to $203.307 million from $214.02 million a year ago...Reuters
Mon, May 5
Fidelity National Financial Inc expected to post earnings of $1.10 a share - Earnings Preview
Fidelity National Financial Inc FNF.N, FNF is expected to show a rise in quarterly revenue when it reports results on May 7 for the period ending March 31 2025The Jacksonville Florida-based company is expected to report a 0.8% increase in revenue to $3.324 billion from $3.3 billion a year ago, acc...Reuters
Mon, May 5
Emergent BioSolutions Inc expected to post earnings of 44 cents a share - Earnings Preview
Emergent BioSolutions Inc EBS.N, EBS is expected to show a fall in quarterly revenue when it reports results on May 7 for the period ending March 31 2025The Gaithersburg Maryland-based company is expected to report a 27.1% decrease in revenue to $219 million from $300.4 million a year ago, accordi...Reuters
Mon, May 5
Lutnick says getting a trade deal with Canada is 'really complex' -Fox Business
May 5 (Reuters) - U.S. Commerce Secretary Howard Lutnick, in an interview with Fox Business on Monday, said getting a trade deal with Canada is going to be complex, and said that a meeting between President Donald Trump and Canadian Prime Minister Mark Carney will be "fascinating.""I thi...Reuters
Mon, May 5
Atara Biotherapeutics Says FDA Lifts Clinical Hold Enabling Resumption Of Clinical Trials
May 5 (Reuters) - Atara Biotherapeutics Inc ATRA.O:ATARA BIOTHERAPEUTICS INC - FDA LIFTS CLINICAL HOLD ENABLING RESUMPTION OF CLINICAL TRIALSATARA BIOTHERAPEUTICS INC - FDA HAS GRANTED A TYPE A MEETING TO DISCUSS PATH FORWARD FOR BLAReuters
Mon, May 5
Protagonist Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Protagonist Therapeutics Inc PTGX.OQ PTGX.O is expected to show a fall in quarterly revenue when it reports results on May 5 (estimated) for the period ending March 31 2025The Newark California California-based company is expected to report a 88.1% decrease in revenue to $30.444 million from $254....Reuters
Mon, May 5
Trump signals an announcement on medicine costs coming next week
WASHINGTON, May 5 (Reuters) - President Donald Trump said on Monday he will make an announcement next week on the costs of medicines.Trump said to reporters gathered at the White House the U.S. was being ripped off on medicine costs when compared to the rest of the world.Reuters
Mon, May 5
Rivian to build $120 million supplier park in Illinois
May 5 (Reuters) - Rivian RIVN.O said on Monday it would invest $120 million to build a supplier park near its plant in Illinois, as the electric vehicle-maker gears up to produce its smaller, more affordable R2 SUVs next year.The supplier park near Rivian's facility at Normal, Illinois will redu...Reuters
Mon, May 5
Janux Therapeutics Inc expected to post a loss of 39 cents a share - Earnings Preview
Janux Therapeutics Inc JANX.OQ JANX.O is expected to show a fall in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025The San Diego California-based company is expected to report a 55.1% decrease in revenue to $562.5 thousand from $1.25 million a yea...Reuters
Mon, May 5
iA Financial Corporation Inc expected to post earnings of C$2.74 a share - Earnings Preview
iA Financial Corporation Inc IAG.TO is expected to report resultson May 7 for the period ending March 31 2025LSEG's mean analyst estimate for iA Financial Corporation Inc is for earnings of C$2.74 per share. The current average analyst rating on the shares is "buy" and the breakdown of...Reuters
Mon, May 5
